Expression of functional interieukin-3 receptors on Hodgkin and Reed-Sternberg cells

被引:47
作者
Aldinucci, D
Poletto, D
Gloghini, A
Nanni, P
Degan, M
Perin, T
Ceolin, P
Rossi, FM
Gattei, V
Carbone, A
Pinto, A
机构
[1] Ist Nazl Tumori, IRCCS, Ctr Riferimento Oncol, Clin Expt Hematol Res Unit, I-33081 Aviano, Italy
[2] Ist Nazl Tumori, IRCCS, Ctr Riferimento Oncol, Div Pathol, I-33081 Aviano, Italy
关键词
D O I
10.1016/S0002-9440(10)64878-X
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The human interleukin-3 receptor (IL-3R) is a heterodimeric complex consisting of an IL-3-specific alpha chain (IL-3Ralpha) and a common beta chain (beta(c)), this latter shared with the receptors for granulocyte-macrophage colony-stimulating factor and IL-5. Despite extensive research on cytokine circuitries regulating proliferation and survival of tumor cells in Hodgkin's disease (HD) the functional expression of IL-3Rs in this pathobiological entity has not yet been investigated. In the present study, we demonstrate that the great majority (>90%) of malignant Hodgkin and Reed-Sternberg cells of classic HD (11.9 of 19 analyzed cases) express IL-3Ralpha by immunostaining of frozen sections and cell suspensions from involved lymph nodes. Accordingly, HD cell lines (L428, KMH2, HDLM2, L1236) expressed the alpha and beta chains of IL-3R both at the mRNA and protein level, with a molecular size of IL-3Ralpha identical (70 kd) to that expressed by human myeloid cells. Exogenous IL-3 promoted the growth of cultured Hodgkin and Reed-Sternberg cells, such effect being potentiated by IL-9 co-stimulation, and was able to partially rescue tumor cells from apoptosis induced by serum deprivation. This data suggests an involvement of IL-3/IL-3R interactions in the cellular growth of HD through paracrine mechanisms.
引用
收藏
页码:585 / 596
页数:12
相关论文
共 68 条
[1]   THE HISTOPATHOLOGIC DIAGNOSIS AND SUBCLASSIFICATION OF HODGKINS-DISEASE [J].
ANASTASI, J ;
BITTER, MA ;
VARDIMAN, JW .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1989, 3 (02) :187-204
[2]   Contribution of interleukin-3 to antigen-induced Th2 cytokine production [J].
Aoki, I ;
Tanaka, S ;
Ishii, N ;
Minami, M ;
Klinman, DM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (06) :1388-1393
[3]   The structural and functional basis of cytokine receptor activation: Lessons from the common beta subunit of the granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3), and IL-5 receptors [J].
Bagley, CJ ;
Woodcock, JM ;
Stomski, FC ;
Lopez, AF .
BLOOD, 1997, 89 (05) :1471-1482
[4]   Immunobiology of dendritic cells [J].
Banchereau, J ;
Briere, F ;
Caux, C ;
Davoust, J ;
Lebecque, S ;
Liu, YT ;
Pulendran, B ;
Palucka, K .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :767-+
[5]   INTERLEUKIN-3 AND INTERLEUKIN-6 SYNERGISTICALLY PROMOTE THE PROLIFERATION AND DIFFERENTIATION OF MALIGNANT PLASMA-CELL PRECURSORS IN MULTIPLE-MYELOMA [J].
BERGUI, L ;
SCHENA, M ;
GAIDANO, G ;
RIVA, M ;
CALIGARISCAPPIO, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (02) :613-618
[6]   Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs [J].
Blalock, WL ;
Weinstein-Oppenheimer, C ;
Chang, F ;
Hoyle, PE ;
Wang, XY ;
Algate, PA ;
Franklin, RA ;
Oberhaus, SM ;
Steelman, LS ;
McCubrey, JA .
LEUKEMIA, 1999, 13 (08) :1109-1166
[7]   EXPRESSION OF FUNCTIONAL CD30 ANTIGEN ON REED-STERNBERG CELLS AND HODGKINS-DISEASE CELL-LINES [J].
CARBONE, A ;
GLOGHINI, A ;
GATTEI, V ;
ALDINUCCI, D ;
DEGAN, M ;
DEPAOLI, P ;
ZAGONEL, V ;
PINTO, A .
BLOOD, 1995, 85 (03) :780-789
[8]  
CARBONE A, 1992, CANCER, V70, P2691, DOI 10.1002/1097-0142(19921201)70:11<2691::AID-CNCR2820701121>3.0.CO
[9]  
2-2
[10]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159